...
首页> 外文期刊>Medicine. >Prognostic significance of preoperative albumin to fibrinogen ratio associated nomograms in patients with breast invasive ductal carcinoma
【24h】

Prognostic significance of preoperative albumin to fibrinogen ratio associated nomograms in patients with breast invasive ductal carcinoma

机译:术前白蛋白对乳腺侵袭性导管癌患者患者纤维蛋白酶生成的预后意义

获取原文

摘要

Plasma albumin to fibrinogen ratio is involved in human cancer, but its prognostic significance in breast cancer is controversy. In the context of breast invasive ductal carcinoma , this research aims to retrospectively evaluate by preoperative plasma albumin to fibrinogen ratio (AFR) and forecast oncological outcome and recurrence. This retrospective study comprised 230 patients with non-metastatic breast invasive ductal carcinoma who underwent surgery between January 2009 and April 2012 in Fourth Hospital of Hebei Medical University. Patients were categorized base on an optimal value of preoperative plasma fibrinogen (Fib) and albumin. Progression-free and cancer-specific survival were assessed using Kaplan–Meier method. The associations between albumin to fibrinogen ratio and clinical outcomes were assessed with univariate and multivariate analysis. A number of risk factors were used to form nomograms to evaluate survival, and Harrell concordance index (C-index) was used to evaluate the predictive accuracy. Plasma AFR was significantly associated with diminished disease-free survival (DFS) and overall survival (OS). Multivariate analysis revealed that plasma AFR was an independent prognostic indicator for DFS (HR = 1.346; 95% CI: 1.107–1.636; P = .03) and overall survival (OS) (HR = 1.485; 95% CI: 1.106–1.993; P = .008). Two prediction model of 3-, 5-years OS and DFS based on the AFR was developed. Elevated preoperative plasma AFR is an independent prognostic factor for oncological outcomes in patients with breast invasive ductal carcinoma . The formulated nomogram showed superior predictive accuracy for DFS and OS.
机译:血浆白蛋白与纤维蛋白原比参与人体癌症,但其在乳腺癌中的预后意义是争议。在乳腺侵入导管癌的背景下,该研究旨在通过术前血浆白蛋白至纤维蛋白原比(AFR)和肿瘤政治结果和复发来回顾性地评估。该回顾性研究包括230例患有230例非转移性乳房侵袭性导管癌,在河北医科大学第四次和2012年4月至2012年4月之间进行了手术。患者被分类为术前血浆纤维蛋白原(FIB)和白蛋白的最佳值。使用Kaplan-Meier方法评估无进展和特异性的存活。使用单变量和多变量分析评估白蛋白与纤维蛋白原率和临床结果之间的缔合。使用许多危险因素来形成载体以评估生存,并使用Harrell Concordance指数(C-Index)来评估预测准确性。血浆AFR显着与无病生存率(DFS)和总存活率(OS)显着相关。多变量分析显示,血浆AFR是DFS的独立预后指示剂(HR = 1.346; 95%CI:1.107-1.636; p = .03)和总存活(OS)(HR = 1.485; 95%CI:1.106-1.993; p = .008)。基于AFR的3-,5年OS和DFS的两个预测模型。近术前血浆AFR是乳腺侵入性导管癌患者的肿瘤性肿瘤结果的独立预后因素。配制的NOM图显示了DFS和OS的卓越的预测精度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号